Insulin injection device

By using hydrocolloid dressing and self-adhesive silicone film in the patch assembly of the insulin injection device, the problems of skin itching and blisters after insulin injection are solved, achieving a more comfortable usage experience and reducing adverse subcutaneous reactions.

CN222033259UActive Publication Date: 2024-11-22CHINESE PEOPLES ARMED POLICE FORCE CHONGQING CORPS HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202420382717.6
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-02-29
Publication Date
2024-11-22
Estimated Expiration
2034-02-28

AI Technical Summary

Technical Problem

After the existing insulin injection device is used, patients are prone to problems such as itching in the skin and blisters around the skin.

Method used

An insulin injection device including a syringe body and a patch assembly is designed, which contains a hydrocolloid dressing and self-adhesive silicone film, fixed to the insulin pump needle, connected to the syringe body through a hose, reducing skin contact and providing Self-adhesive protection.

Benefits of technology

It effectively reduces the skin itching and blisters of patients when using insulin injection devices, simplifies the operation process and prevents subcutaneous nodules and adverse absorption problems caused by repeated injections of the same site in a short period of time.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222033259U_ABST
    Figure CN222033259U_ABST
Patent Text Reader

Abstract

The utility model discloses an insulin injection device which comprises an injector body and an application component, the injector body is connected with the application component through a hose, the application component comprises a connecting seat, a connecting pipe is arranged on one side of the connecting seat, the hose is detachably connected into the connecting pipe, a containing cavity is formed in the bottom end of the connecting seat, and the hose is detachably connected into the containing cavity. The surface of the containing cavity is fixedly connected with an insulin pump needle, and an application is arranged at the lower end of the connecting base. By the adoption of the technical scheme, a patient can conveniently use the insulin pump, and meanwhile the conditions of skin itch, skin blister and other symptoms of the patient can be reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical equipment, in particular to an insulin injection device. Background Art

[0002] Diabetes is a metabolic disease characterized by hyperglycemia due to defective insulin secretion or impaired insulin action. Continuous hyperglycemia and long-term metabolic disorders can lead to damage to tissues and organs throughout the body, especially the eyes, kidneys, cardiovascular and nervous systems, as well as dysfunction and failure. In severe cases, it can cause acute complications such as dehydration, electrolyte imbalance and acid-base imbalance, such as ketoacidosis and hyperosmolar coma. Insulin therapy is the main means to achieve good blood sugar control, and a large proportion of diabetic patients need to inject insulin multiple times a day.

[0003] The existing insulin injection device has the following problems: after using the insulin injection device, the patient is prone to skin itching, blisters around the skin and other problems. Utility Model Content

[0004] The utility model aims to provide an insulin injection device to solve the problems existing in the existing insulin injection devices.

[0005] In order to achieve the above object, the utility model provides the following technical solutions:

[0006] An insulin injection device comprises a syringe body and an application assembly, wherein the syringe body and the application assembly are connected via a hose, the application assembly comprises a connecting seat, a connecting tube is provided on one side of the connecting seat, a hose is detachably connected to the connecting tube, a accommodating cavity is provided at the bottom end of the connecting seat, an insulin pump needle is fixedly connected to the surface of the accommodating cavity, and an application is provided at the lower end of the connecting seat.

[0007] Preferably, the dressing comprises a hydrocolloid dressing fixedly connected to the surface of the insulin pump needle and a self-adhesive silicone film adhered to the surface of the hydrocolloid dressing.

[0008] Preferably, the syringe body comprises an injection needle mounted on the syringe body.

[0009] Preferably, the hydrocolloid dressing, insulin pump needle and self-adhesive silicone film are designed as an integrated whole.

[0010] Preferably, the insulin pump needle and the injection needle are also provided with a needle cap.

[0011] Preferably, an indicator strip is also provided on the patch.

[0012] Compared with the prior art, the beneficial effects of the present invention are: it is convenient for patients to use the insulin pump, and at the same time it can reduce the symptoms of patients such as skin itching and skin blisters. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 A schematic diagram of the structure of an insulin injection device provided by an embodiment of the utility model;

[0014] Figure 2 It is a schematic diagram of the structure of the syringe body;

[0015] Figure 3 A front cross-sectional view of the applicator assembly. DETAILED DESCRIPTION

[0016] The present invention is further described in detail below in conjunction with the accompanying drawings and implementation examples:

[0017] The figure marks in the drawings of the specification include: 1. syringe body; 2. hose; 3. connecting seat; 4. connecting tube; 5. accommodating chamber; 6. insulin pump needle; 7. dressing; 8. hydrocolloid dressing; 9. self-adhesive silicone film; 10. injection needle.

[0018] As shown in the figure, an insulin injection device includes a syringe body 1 and an application 7 component, wherein the syringe body 1 includes an injection needle 10 installed on the syringe body 1. The syringe body 1 is connected to the application 7 component through a hose 2, and the application 7 component includes a connecting seat 3, a connecting tube 4 is provided on one side of the connecting seat 3, and a hose 2 is detachably connected to the connecting tube 4, and a receiving cavity 5 is provided at the bottom end of the connecting seat 3, and an insulin pump needle 6 is fixedly connected to the surface of the receiving cavity 5, and an application 7 is provided at the lower end of the connecting seat 3, and the application 7 includes a hydrocolloid dressing 8 fixedly connected to the surface of the insulin pump needle 6 and a self-adhesive silicone film 9 pasted on the surface of the hydrocolloid dressing 8. The use of the self-adhesive silicone film 9 can reduce the patient's skin itching, blisters around the skin and other problems. The integrated design of the hydrocolloid dressing 8, the insulin pump needle 6, and the self-adhesive silicone film 9 can simplify the steps and facilitate the operation of medical staff. Needle caps are also provided on the insulin pump needle 6 and the injection needle 10. An indicator strip is also provided on the patch 7 to serve as a reminder to avoid problems such as subcutaneous nodules and poor absorption caused by repeated injections of the same site in a short period of time.

[0019] The above is only an embodiment of the utility model, and the common knowledge such as the known specific technical solutions and / or characteristics in the solution is not described in detail here. It should be pointed out that for those skilled in the art, without departing from the technical solution of the utility model, several deformations and improvements can be made, which should also be regarded as the protection scope of the utility model, and these will not affect the effect of the implementation of the utility model and the practicality of the patent. The scope of protection required by this application shall be based on the content of its claims, and the specific implementation methods and other records in the specification can be used to interpret the content of the claims.

Claims

1. An insulin injection device, characterized in that: The invention comprises a syringe body (1) and an application (7) assembly, wherein the syringe body (1) and the application (7) assembly are connected via a hose (2), the application (7) assembly comprises a connecting seat (3), a connecting tube (4) is arranged on one side of the connecting seat (3), the hose (2) is detachably connected to the connecting tube (4), a receiving cavity (5) is arranged at the bottom end of the connecting seat (3), an insulin pump needle (6) is fixedly connected to the surface of the receiving cavity (5), and an application (7) is arranged at the lower end of the connecting seat (3).

2. The insulin injection device according to claim 1, characterized in that: The dressing (7) comprises a hydrocolloid dressing (8) fixedly connected to the surface of an insulin pump needle (6) and a self-adhesive silicone film (9) adhered to the surface of the hydrocolloid dressing (8).

3. The insulin injection device according to claim 1, characterized in that: The syringe body (1) comprises an injection needle (10) mounted on the syringe body (1).

4. The insulin injection device according to claim 2, characterized in that: The hydrocolloid dressing (8), the insulin pump needle (6), and the self-adhesive silicone film (9) are designed as an integrated whole.

5. The insulin injection device according to claim 3, characterized in that: The insulin pump needle (6) and the injection needle (10) are also provided with needle caps.

6. The insulin injection device according to claim 2, characterized in that: The patch (7) is also provided with an indicator strip.